⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RIGL News
Rigel Pharmaceuticals Inc. (New)
Rigel Reports Second Quarter 2026 Financial Results
prnewswire.com
RIGL
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ARVN
RIGL
STARTRADER expands AI offering with 31 New US Share & ETF CFDs in Semiconductors, Optical Networking & Nuclear
prnewswire.com
ON
WOLF
ASTL
RIGL
SMTC
VSH
AXTI
VRT
CIEN
APO
FABC
NOK
Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)
globenewswire.com
RIGL
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
prnewswire.com
RIGL
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
Form 8-K
sec.gov
RIGL
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer
prnewswire.com
RIGL
Form 8-K
sec.gov
RIGL
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
prnewswire.com
RIGL
ARVN
PFE